Engagement with the HCV care cascade among high-risk groups: A population-based study

Author:

Erman Aysegul12ORCID,Everett Karl2ORCID,Wong William W.L.123ORCID,Forouzannia Farinaz3ORCID,Greenaway Christina4ORCID,Janjua Naveed5ORCID,Kwong Jeffrey C.26ORCID,Sander Beate127ORCID

Affiliation:

1. Toronto Health Economics and Technology Assessment Collaborative (THETA), University Health Network, Toronto, ON, Canada

2. ICES, Toronto, Ontario, Canada

3. School of Pharmacy, University of Waterloo, Kitchener, ON, Canada

4. Division of Infectious Diseases, Jewish General Hospital, McGill University, Montreal, QC, Canada

5. British Columbia Centre for Disease Control (BCDC), Vancouver, BC, Canada

6. University of Toronto

7. Public Health Ontario, Toronto, Ontario, Canada

Abstract

Background: HCV elimination requires a thorough understanding of the care cascade. A direct-acting antiviral (DAA)-era description of the care cascade has not been undertaken in Ontario, Canada’s most populous jurisdiction. Our primary objective was to describe the current population-level care cascade in the general Ontario population and among key risk groups ─ baby boomers, immigrants, and individuals experiencing residential instability. The secondary objective was to identify predictors of engagement. Methods: We conducted a population-based cohort study of Ontario residents undergoing HCV testing between January 1, 1999, and December 31, 2018, and mapped the care cascade [antibody-diagnosed, RNA tested, RNA positive, genotyped, treated, achieved sustained virologic response, reinfected/relapsed] as of December 31, 2018. The cascade was stratified by risk groups. Cause-specific hazard modeling was used to identify demographic, and socioeconomic predictors of engagement with key steps of the cascade. Results: Among 108,428 Ontario residents living with an HCV antibody diagnosis, 88% received confirmatory RNA testing; of these, 62% tested positive and 94% of positive tests were genotyped. Of those with confirmed viremia, 53% initiated treatment and 76% of treated individuals achieved sustained virologic response, while ~1% experienced reinfection or relapse. Males, older birth cohorts, long-term residents, those with a history of substance use disorder and social marginalization (eg, material deprivation, residential instability), and those initially diagnosed in the pre-DAA era exhibited lower rates of engagement with almost every step of HCV care. Conclusions: Despite DAA era improvements, treatment initiation remains a major gap. HCV screening and linkage-to-treatment, particularly for those with a history of substance use disorder and social marginalization, will be needed to equitably close gaps in HCV care in the province.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Reference18 articles.

1. Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents;Yasseen;Liver Inter [Internet],2021

2. Hepatitis C virus infection in First Nations populations in Ontario from 2006 to 2014: a population-based retrospective cohort analysis;Mendlowitz;Can Med Assoc Open Access J [Internet],2021

3. Model-based projection of health and economic effects of screening for hepatitis C in Canada;Wong;CMAJ-Open [Internet],2017

4. Estimating chronic hepatitis C prevalence in British Columbia and Ontario, Canada, using population-based cohort studies;Hamadeh;J Viral Hepat [Internet],2020

5. Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting;Kim;BMC Public Health [Internet],2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3